Wendy is a pharmacist by training, having graduated from Beijing Traditional Chinese Medicine University (China) and received an MBA from Staffordshire University (UK).  She began her career in Beijing Drug Control Institute, subordinate organization of China NMPA in 1988. Since 1996, she had held multiple leading Regulatory Affairs positions at several multinational pharmaceutical companies for 18 years. Wendy joined BeiGene as the Senior Vice President, Global Head of Regulatory Affairs in August 2014. She was appointed as Senior Vice President, Chief Regulatory Officer since 2021.  Wendy has been former Member of DIA Advisory Council of China (ACC). Wendy is Professor of YEEHONG Business School. She is DIA board members as observer.